◆ 会议时间：2024年5月19日至22日
◆ 会议地点：葡萄牙 里斯本
◆ 会议简介：
2024年第29届世界帕金森病及相关疾病大会将于2024年5月19日至22日在葡萄牙里斯本举行，会议由国际帕金森病及相关疾病协会(IAPRD)主办。
国际帕金森病及相关疾病协会(IAPRD)前身为世界神经病学联盟帕金森氏症及相关疾病研究小组，2010年在Erik Wolters博士与Zbigniew Wszolek博士倡议下改为现名并成为一个独立的组织。IAPRD是一个由临床医生、科学家和其他相关专业人士宣组成的国际性专业协会，他们对神经退行性疾病感兴趣，如帕金森病、继发性帕金森症、多动和少动运动障碍，以及其他影响肌肉张力和运动控制的任何疾病；与运动障碍有关的非运动障碍，例如自主神经系统疾病，情绪障碍，睡眠障碍（包括：白天过度嗜睡，REM睡眠行为障碍，不安腿综合症和周期性肢体运动）和精神疾病（包括：冲动控制障碍，执行功能障碍，痴呆，妄想和幻觉）等等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。
IAPRD 2024
29th World Congress on Parkinson’s Disease and Related Disorders
时间/Date:
19-22 May 2024
地点/Venue:
Lisbon, Portugal
Organized by：
International Association of Parkinsonism and Related Disorders(IAPAD)
摘要征文投稿：
Abstract Submission Deadline: 28 Jan 2024 (23:59 CEST)
All submitters will be notified by e-mail in March 2024 about the acceptance.
Submit your abstract here
- Basic Neuroscience (excluding Genetics)
- Imaging and Biomarkers
- Neurosurgery (including Deep Brain Stimulation)
- Behavior, Cognition, Psychiatry
- Parkinson Disease: Genetics
- Parkinson Disease: Subtypes, natural course
- Parkinson Disease: Clinical assessment (including devices)
- Parkinson Disease: Therapy (excluding surgical, physical)
- Parkinson Disease: Other topics
- Other Parkinsonian Disorders
- Dystonia
- Chorea, Athetosis, Ballism, Tics
- Ataxias, hereditary spastic paraparesis
- Tremors, Myoclonus
- Gait Disturbances and Other Movement Disorders
- Rehabilitation, Nursing/Physiotherapy, Other Allied Health; Patient Participation
Welcome to IAPRD 2024 in Lisbon, Portugal!
On behalf of the International Association of Parkinsonism and Related Disorders (IAPRD), it is our pleasure to invite you to join us for the XXIX World Congress on Parkinson’s Disease and Related Disorders to be held 19-22 May 2024 in Lisbon, Portugal.
The IAPRD 2024 Congress features a comprehensive program in movement disorders led by renowned faculty from across the globe, focusing on the theme of Discovering New Horizons in Movement Disorders: Strengthening Foundations and Sharing Advances. IAPRD 2024 offers 3.5 days of clinically-relevant disease and treatment overviews and updates, complemented by workshops and educational/foundational sessions designed to aid diagnosis and management. Our smaller meetings provide ample opportunities for interactions and professional development, set in a format that promotes scientific exchange.
Lisbon is renowned for its stunning, ornate architecture, traditional Fado music, and historic landmarks that recall Portugal’s seafaring past. Join us in Lisbon for IAPRD 2024, the perfect place to forge new connections and expand your own horizons.
Karen Frei, MD
SPEC Chair
Marie-Helene Saint-Hilaire, MD
SPEC Co-Chair
Miguel Coelho, MD, Prof.
Congress Chair
Miguel Gago, MD
Congress Chair
注册费：
| Registration Type |
Early Bird Fee until 31 March 2024
|
Regular Fee |
| IAPRD Full Member / Fellow* |
€ 250 |
€ 500 |
| IAPRD Full Member / Fellow* (lower & lower middle income countries)** |
€ 250 |
€ 380 |
| Regular Congress Ticket (Non-IAPRD Member) |
€ 595 |
€ 695 |
| Reduced fee (lower & lower middle income countries)** |
€ 295 |
€ 420 |
| Students, Residents, Trainees and Fellows*** |
€ 50 |
€ 150 |
| Allied Health Professionals |
€ 445 |
€ 520 |
| Press*** |
€ 0 |
€ 0 |
The registration fees will be charged in € for all attendees.
* IAPRD members in good standing . Member status will be checked upon registration to the congress.
** Participants from lower & lower middle income countries: list according to World Bank list of economies: please click here
*** Copy of student ID / press ID is required. Residents/Fellows/Trainees: Born after May 19, 1989 and/or still in training.
The registration fee includes
- Access to the scientific sessions
- Access to the exhibition
- Certificate of attendance
- Printed copy of the scientific program
- Networking reception on Sunday, 19 May 2024 and daily coffee breaks
The congress provides a collegial atmosphere to meet, interact and network with colleagues from around the world who are interested in the field of Parkinson’s Diseases.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
